Login

CEOTalks featuring Tomás Córdoba, Presidente y Director General of MetroGAS, discuss industry insights and innovations. 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Patrik De Haes, CEO, Oxurion
00:10:00
Colonialism: A Moral Reassessment|Nigel Biggar,Professor,Oxford University
00:10:00
Global Growth and Strategic Success: Banco Santander's Strong Start to 2023 | Hector Grisi , CEO , Banco Santander.
00:10:00
Misunderstanding Freud: Unraveling the Philosophical Legacy|Mikkel Borch-Jacobsen,Professor,
00:10:00
Charting Future Frontiers: Insights from the GF Analyst and Media Conference 2024 | Andreas Müller - CEO of Georg Fischer
00:10:00
Adapting to Change: Andrew Canobi on Innovative Fixed Income Strategies with Franklin Australian Absolute Return Bond Fund | Andrew Canobi - Director, Australian Fixed Income, Franklin Templeton
00:10:00
Mastering Volatility and Skew to Deliver Rare Alpha in Crowded, Convex Markets|Nigol Koulajian,CIO,AlphaQuest
00:10:00
Understanding the 72(q)/72(t) Early Distribution Method | Dylan Potter - VICE PRESIDENT, WEALTH MANAGER of Howe & Rusling, Inc.
00:10:00
Sprott Asset Management CEO John Ciampaglia discusses the launch of the Sprott Energy Transition with Proactive's Natalie Stoberman.
00:10:00
Milbank@Harvard Professional Development Program
00:10:00
backing great entrepreneurs at the earliest stages|Satish Dharmaraj,Managing Director,Redpoint
00:10:00
AltaIR Capital is looking for great teams to support through their journey|Dmitry Firskin,Principal, AltaIR Capital

© 2017 - Neuhu+